INSP Stock Recent News
INSP LATEST HEADLINES
Kratos Defense, Montrose Environmental, and Karman Holdings drove strong quarterly performance, benefiting from secular tailwinds and robust demand in defense and environmental sectors. We see Kratos and Karman as well positioned for multi-year growth, leveraging investments in hypersonics, missile defense, and space technologies amid rising defense budgets. Montrose Environmental rebounded as regulatory fears eased, organic growth accelerated, and debt reduction improved transparency, supporting our continued conviction in its long-term value.
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES--(BUSINESS WIRE)---- $INSP--INSP Investors Have Opportunity to Join Inspire Medical Systems, Inc. Fraud Investigation with the Schall Law Firm.
Inspire Medical Systems, Inc. INSP reported second-quarter results and cut its FY25 guidance below estimates on Monday.
ATLANTA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) complied with federal securities laws. On August 4, 2025, Inspire Medical announced second quarter 2025 results and updated its 2025 outlook, stating that “the U.S. commercial launch is progressing slower than expected, and the timeline to complete the full transition to Inspire V has been pushed forward, which will impact financial results for the year.” Following this news, the price of the Company's stock dropped.
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
Block & Leviton LLP is investigating Inspire Medical Systems (NYSE: INSP) for potential securities fraud. Investors who lost money should contact the firm.
Inspire Medical Systems crashed Tuesday after the maker of implantable sleep apnea devices called out GLP-1 drugs for weighing on sales.
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.1% on Tuesday.